Breaking News Instant updates and real-time market news.

BLDR

Builders FirstSource

$22.41 /

+0.19 (+0.86%)

05:34
06/05/20
06/05
05:34
06/05/20
05:34

Builders FirstSource downgraded to In Line from Outperform at Evercore ISI

Evercore ISI analyst Trey Morrish downgraded Builders FirstSource to In Line from Outperform with a $24 price target.

  • 17

    Jun

BLDR Builders FirstSource
$22.41 /

+0.19 (+0.86%)

05/05/20 Deutsche Bank
Builders FirstSource downgraded to Hold from Buy at Deutsche Bank
05/04/20 BTIG
Builders FirstSource price target lowered to $23 from $31 at BTIG
04/09/20 DA Davidson
Builders FirstSource price target lowered to $20 from $33 at DA Davidson
03/17/20 B. Riley Securities
B. Riley FBR downgrades seven Industrials on broadening COVID-19 impact

TODAY'S FREE FLY STORIES

Recommendations
W.R. Grace response to 40 North suggests higher odds of deal, says Wells Fargo » 19:46
01/15/21
01/15
19:46
01/15/21
19:46
GRA

W.R. Grace

$63.29 /

+4.64 (+7.91%)

Wells Fargo analyst…

Wells Fargo analyst Michael Sison said W.R. Grace's letter in response to 40 North Management's unsolicited $65 per share offer, which expressed a willingness to discuss a sale and to share additional information with 40 North to support a full valuation, suggests an "increased likelihood of an agreement coming to fruition." The analyst, who would expect more details on the path towards a deal to be supportive of the shares, has an Equal Weight rating on W.R. Grace.

ShowHide Related Items >><<
GRA W.R. Grace
$63.29 /

+4.64 (+7.91%)

GRA W.R. Grace
$63.29 /

+4.64 (+7.91%)

11/10/20 Loop Capital
W.R. Grace price target raised to $60 from $46 at Loop Capital
11/10/20 BMO Capital
W.R. Grace price target raised to $64 from $51 at BMO Capital
11/10/20 Baird
W.R. Grace low offer could be to attract other bids, says Baird
10/29/20 Monness Crespi
W.R. Grace shares have 'significant upside potential,' says Monness Crespi
GRA W.R. Grace
$63.29 /

+4.64 (+7.91%)

GRA W.R. Grace
$63.29 /

+4.64 (+7.91%)

Periodicals
Roblox hires GTS for its direct listing, Business Insider says » 17:45
01/15/21
01/15
17:45
01/15/21
17:45
RBLX

Roblox

$0.00 /

+ (+0.00%)

Video game maker Roblox…

Video game maker Roblox has hired GTS for its direct listing as part of an attempt to go public, Business Insider's Dakin Campbell reports. The move will mark the first time GTS has been selected to help a major technology firm make its public markets debut through a direct listing, Campbell says. Reference Link

ShowHide Related Items >><<
RBLX Roblox
$0.00 /

+ (+0.00%)

RBLX Roblox
$0.00 /

+ (+0.00%)

RBLX Roblox
$0.00 /

+ (+0.00%)

Hot Stocks
REV Group CFO buys 15K shares of common stock » 17:35
01/15/21
01/15
17:35
01/15/21
17:35
REVG

REV Group

$9.12 /

+0.05 (+0.55%)

In a regulatory filing,…

In a regulatory filing, REV Group disclosed that is CFO Mark Skonieczny bought 15K shares of common stock on January 13th in a total transaction size of $136.4K, boosting his stake by about 9%.

ShowHide Related Items >><<
REVG REV Group
$9.12 /

+0.05 (+0.55%)

REVG REV Group
$9.12 /

+0.05 (+0.55%)

01/08/21 Baird
REV Group result pretty much as expected, says Baird
12/17/20 Baird
REV Q4 results delay could portend impending portfolio realignment, says Baird
12/15/20 Morgan Stanley
REV Group upgraded to Equal Weight on improved RV outlook at Morgan Stanley
12/15/20 Morgan Stanley
REV Group upgraded to Equal Weight from Underweight at Morgan Stanley
REVG REV Group
$9.12 /

+0.05 (+0.55%)

REVG REV Group
$9.12 /

+0.05 (+0.55%)

Hot Stocks
Halozyme says Janssen receives FDA approval of Darzalex Faspro » 17:32
01/15/21
01/15
17:32
01/15/21
17:32
JNJ

Johnson & Johnson

$160.28 /

-0.37 (-0.23%)

, HALO

Halozyme

$47.42 /

+0.38 (+0.81%)

Halozyme Therapeutics…

Halozyme Therapeutics (HALO) announced that Janssen Biotech, Inc. (JNJ) has received U.S. Food and Drug Administration approval of DARZALEX FASPRO in combination with bortezomib, cyclophosphamide and dexamethasone for the treatment of adult patients with newly diagnosed light chain amyloidosis. DARZALEX FASPRO is the first and only FDA-approved treatment for patients with this rare and serious blood disorder associated with the production of an abnormal protein which leads to the deterioration of vital organs, most notably the heart, kidneys and liver.1 This indication is approved under accelerated approval and is based on the combination's hematologic complete response rate measure. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial. DARZALEX FASPRO is not indicated and is not recommended for the treatment of patients with light chain amyloidosis who have NYHA Class IIIB or Class IV cardiac disease or Mayo Stage IIIB outside of controlled clinical trials.

ShowHide Related Items >><<
JNJ Johnson & Johnson
$160.28 /

-0.37 (-0.23%)

HALO Halozyme
$47.42 /

+0.38 (+0.81%)

JNJ Johnson & Johnson
$160.28 /

-0.37 (-0.23%)

01/15/21 B. Riley Securities
Arcturus Therapeutics downgraded to Neutral from Buy at B. Riley Securities
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
01/14/21 Oppenheimer
Essa Pharma price target raised to $20 from $9 at Oppenheimer
12/29/20 Piper Sandler
Piper still believes in Arcturus vaccine after 'underwhelming' immunogenicity
HALO Halozyme
$47.42 /

+0.38 (+0.81%)

01/14/21 Piper Sandler
Halozyme price target raised to $50 from $42 at Piper Sandler
01/11/21 Benchmark
Phesgo EU approval/Horizon deal fuel Halozyme increased guidance, says Benchmark
01/05/21 Benchmark
GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021
12/17/20 Berenberg
Halozyme initiated with a Buy at Berenberg
JNJ Johnson & Johnson
$160.28 /

-0.37 (-0.23%)

HALO Halozyme
$47.42 /

+0.38 (+0.81%)

JNJ Johnson & Johnson
$160.28 /

-0.37 (-0.23%)

JNJ Johnson & Johnson
$160.28 /

-0.37 (-0.23%)

HALO Halozyme
$47.42 /

+0.38 (+0.81%)

JNJ Johnson & Johnson
$160.28 /

-0.37 (-0.23%)

Syndicate
Akerna files to sell 6.12M shares of common stock for holders  17:29
01/15/21
01/15
17:29
01/15/21
17:29
KERN

Akerna

$6.33 /

-0.23 (-3.51%)

 
ShowHide Related Items >><<
KERN Akerna
$6.33 /

-0.23 (-3.51%)

KERN Akerna
$6.33 /

-0.23 (-3.51%)

11/12/20 Alliance Global Partners
Akerna price target lowered to $8 from $10 at Alliance Global Partners
11/04/20 Alliance Global Partners
Five states legalize cannabis, bullish for Akerna, says Alliance Global Partners
09/24/20 Alliance Global Partners
Akerna post-earnings selloff overdone, says Alliance Global Partners
KERN Akerna
$6.33 /

-0.23 (-3.51%)

KERN Akerna
$6.33 /

-0.23 (-3.51%)

Hot Stocks
Hilltop Holdings to replace Yeti in S&P 600 at open on 1/21 » 17:29
01/15/21
01/15
17:29
01/15/21
17:29
HTH

Hilltop Holdings

$28.39 /

-0.5 (-1.73%)

, YETI

Yeti

$73.93 /

-3.6 (-4.64%)

, TRMB

Trimble

$69.53 /

-0.36 (-0.52%)

Hilltop Holdings (HTH)…

Hilltop Holdings (HTH) will replace YETI Holdings (YETI) in the S&P SmallCap 600 as Yeti is replacing Trimble (TRMB) in the S&P MidCap 400.

ShowHide Related Items >><<
YETI Yeti
$73.93 /

-3.6 (-4.64%)

TRMB Trimble
$69.53 /

-0.36 (-0.52%)

HTH Hilltop Holdings
$28.39 /

-0.5 (-1.73%)

HTH Hilltop Holdings
$28.39 /

-0.5 (-1.73%)

11/02/20 Truist
Hilltop Holdings price target raised to $28 from $24 at Truist
08/14/20 Stephens
Hilltop Holdings upgraded to Overweight from Equal Weight at Stephens
08/14/20 Stephens
Hilltop Holdings upgraded to Overweight from Equal Weight at Stephens
YETI Yeti
$73.93 /

-3.6 (-4.64%)

01/14/21 Citi
Yeti downgraded to Neutral from Buy at Citi
01/14/21 BTIG
Yeti price target raised to $90 from $71 at BTIG
11/06/20 Baird
Yeti price target raised to $70 from $60 at Baird
11/06/20 KeyBanc
Yeti price target raised to $66 from $58 at KeyBanc
TRMB Trimble
$69.53 /

-0.36 (-0.52%)

09/22/20 Bernstein
Trimble initiated with an Outperform at Bernstein
08/25/20 Wolfe Research
Trimble initiated with an Outperform at Wolfe Research
08/10/20 Raymond James
Trimble price target raised to $55 from $44 at Raymond James
05/29/20 Craig-Hallum
Trimble downgraded to Hold from Buy at Craig-Hallum
YETI Yeti
$73.93 /

-3.6 (-4.64%)

TRMB Trimble
$69.53 /

-0.36 (-0.52%)

HTH Hilltop Holdings
$28.39 /

-0.5 (-1.73%)

  • 28
    May
  • 11
    May
  • 17
    Feb
YETI Yeti
$73.93 /

-3.6 (-4.64%)

TRMB Trimble
$69.53 /

-0.36 (-0.52%)

YETI Yeti
$73.93 /

-3.6 (-4.64%)

HTH Hilltop Holdings
$28.39 /

-0.5 (-1.73%)

Periodicals
Lawsuit alleges Amazon drives up price of e-books, WSJ reports » 17:28
01/15/21
01/15
17:28
01/15/21
17:28
AMZN

Amazon.com

$3,105.13 /

-24.86 (-0.79%)

A lawsuit filed in a…

A lawsuit filed in a federal district court in New York is accusing Amazon of forcing customers on other book sites to pay too much for electronic books, the Wall Street Journal's Jeffrey A. Trachtenberg and Dana Mattioli report. The suit alleges that an agreement between Amazon and five major book publishers has led to higher e-book prices for all consumers, since it prevents competing retails from selling any of these publishers' e-books at a lower price than on the ecommerce giant's site, the authors say. The suit is seeking class-action status and claims that Amazon charges high commissions and other costs to publishers, the authors note. Reference Link

ShowHide Related Items >><<
AMZN Amazon.com
$3,105.13 /

-24.86 (-0.79%)

AMZN Amazon.com
$3,105.13 /

-24.86 (-0.79%)

01/11/21 Baird
Baird remains a buyer of Amazon ahead of Q4 results
12/22/20 Wells Fargo
Microsoft's own semis 'a competitive headwind' for Intel, says Wells Fargo
12/16/20 Baird
Baird would be a buyer of Teladoc amid weakness caused by Amazon report
12/14/20 BMO Capital
BMO downgrades Disney after recent run, names new top media pick
AMZN Amazon.com
$3,105.13 /

-24.86 (-0.79%)

AMZN Amazon.com
$3,105.13 /

-24.86 (-0.79%)

AMZN Amazon.com
$3,105.13 /

-24.86 (-0.79%)

AMZN Amazon.com
$3,105.13 /

-24.86 (-0.79%)

Hot Stocks
Yeti to replace Trimble in S&P 400 at open on 1/21 » 17:27
01/15/21
01/15
17:27
01/15/21
17:27
YETI

Yeti

$73.93 /

-3.6 (-4.64%)

, TRMB

Trimble

$69.53 /

-0.36 (-0.52%)

, CXO

Concho Resources

$65.79 /

-4.01 (-5.74%)

YETI Holdings (YETI) will…

YETI Holdings (YETI) will replace Trimble (TRMB) in the S&P MidCap 400 as Trimble is replacing Concho Resources (CXO) in the S&P 500.

ShowHide Related Items >><<
YETI Yeti
$73.93 /

-3.6 (-4.64%)

TRMB Trimble
$69.53 /

-0.36 (-0.52%)

CXO Concho Resources
$65.79 /

-4.01 (-5.74%)

YETI Yeti
$73.93 /

-3.6 (-4.64%)

01/14/21 Citi
Yeti downgraded to Neutral from Buy at Citi
01/14/21 BTIG
Yeti price target raised to $90 from $71 at BTIG
11/06/20 Baird
Yeti price target raised to $70 from $60 at Baird
11/06/20 KeyBanc
Yeti price target raised to $66 from $58 at KeyBanc
TRMB Trimble
$69.53 /

-0.36 (-0.52%)

09/22/20 Bernstein
Trimble initiated with an Outperform at Bernstein
08/25/20 Wolfe Research
Trimble initiated with an Outperform at Wolfe Research
08/10/20 Raymond James
Trimble price target raised to $55 from $44 at Raymond James
05/29/20 Craig-Hallum
Trimble downgraded to Hold from Buy at Craig-Hallum
CXO Concho Resources
$65.79 /

-4.01 (-5.74%)

01/14/21 Scotiabank
Scotiabank upgrades ConocoPhillips on 'overwhelmingly positive' deal
11/20/20 Stifel
Concho Resources downgraded to Hold from Buy at Stifel
11/19/20 Scotiabank
Concho Resources price target raised to $65.70 from $43 at Scotiabank
11/17/20 Morgan Stanley
Concho Resources downgraded to Equal Weight at Morgan Stanley
YETI Yeti
$73.93 /

-3.6 (-4.64%)

TRMB Trimble
$69.53 /

-0.36 (-0.52%)

CXO Concho Resources
$65.79 /

-4.01 (-5.74%)

  • 28
    May
  • 11
    May
  • 17
    Feb
CXO Concho Resources
$65.79 /

-4.01 (-5.74%)

YETI Yeti
$73.93 /

-3.6 (-4.64%)

TRMB Trimble
$69.53 /

-0.36 (-0.52%)

CXO Concho Resources
$65.79 /

-4.01 (-5.74%)

YETI Yeti
$73.93 /

-3.6 (-4.64%)

CXO Concho Resources
$65.79 /

-4.01 (-5.74%)

Hot Stocks
Trimble to replace Concho Resources in S&P 500 at open on 1/21 » 17:25
01/15/21
01/15
17:25
01/15/21
17:25
TRMB

Trimble

$69.53 /

-0.36 (-0.52%)

, CXO

Concho Resources

$65.79 /

-4.01 (-5.74%)

, COP

ConocoPhillips

$45.13 /

-2.74 (-5.72%)

S&P MidCap 400…

S&P MidCap 400 constituent Trimble (TRMB) will replace Concho Resources (CXO) in the S&P 500 effective prior to the opening of trading on Thursday, January 21. ConocoPhillips' (COP) acquisition of Concho Resources has just been completed.

ShowHide Related Items >><<
TRMB Trimble
$69.53 /

-0.36 (-0.52%)

CXO Concho Resources
$65.79 /

-4.01 (-5.74%)

COP ConocoPhillips
$45.13 /

-2.74 (-5.72%)

TRMB Trimble
$69.53 /

-0.36 (-0.52%)

09/22/20 Bernstein
Trimble initiated with an Outperform at Bernstein
08/25/20 Wolfe Research
Trimble initiated with an Outperform at Wolfe Research
08/10/20 Raymond James
Trimble price target raised to $55 from $44 at Raymond James
05/29/20 Craig-Hallum
Trimble downgraded to Hold from Buy at Craig-Hallum
CXO Concho Resources
$65.79 /

-4.01 (-5.74%)

01/14/21 Scotiabank
Scotiabank upgrades ConocoPhillips on 'overwhelmingly positive' deal
11/20/20 Stifel
Concho Resources downgraded to Hold from Buy at Stifel
11/19/20 Scotiabank
Concho Resources price target raised to $65.70 from $43 at Scotiabank
11/17/20 Morgan Stanley
Concho Resources downgraded to Equal Weight at Morgan Stanley
COP ConocoPhillips
$45.13 /

-2.74 (-5.72%)

01/14/21 Barclays
ConocoPhillips price target raised to $59 from $55 at Barclays
01/14/21 Barclays
Barclays upgrades Exxon to Overweight amidst 'perfect storm'
01/14/21 Scotiabank
ConocoPhillips upgraded to Outperform from Sector Perform at Scotiabank
TRMB Trimble
$69.53 /

-0.36 (-0.52%)

CXO Concho Resources
$65.79 /

-4.01 (-5.74%)

COP ConocoPhillips
$45.13 /

-2.74 (-5.72%)

CXO Concho Resources
$65.79 /

-4.01 (-5.74%)

COP ConocoPhillips
$45.13 /

-2.74 (-5.72%)

TRMB Trimble
$69.53 /

-0.36 (-0.52%)

CXO Concho Resources
$65.79 /

-4.01 (-5.74%)

COP ConocoPhillips
$45.13 /

-2.74 (-5.72%)

CXO Concho Resources
$65.79 /

-4.01 (-5.74%)

COP ConocoPhillips
$45.13 /

-2.74 (-5.72%)

Hot Stocks
E.W. Scripps jumps 6% to $15.75 after Berkshire Hathaway disclosed stake  17:25
01/15/21
01/15
17:25
01/15/21
17:25
SSP

E.W. Scripps

$14.85 /

-0.105 (-0.70%)

, BRK.A

Berkshire Hathaway

$350,950.00 /

-2050 (-0.58%)

, BRK.B

Berkshire Hathaway

$233.53 /

-1.61 (-0.68%)

 
ShowHide Related Items >><<
SSP E.W. Scripps
$14.85 /

-0.105 (-0.70%)

BRK.B Berkshire Hathaway
$233.53 /

-1.61 (-0.68%)

BRK.A Berkshire Hathaway
$350,950.00 /

-2050 (-0.58%)

SSP E.W. Scripps
$14.85 /

-0.105 (-0.70%)

10/22/20
Fly Intel: Top five analyst initiations
10/22/20 Guggenheim
E.W. Scripps resumed with a Buy at Guggenheim
07/07/20
Stitcher would help Sirius 'future-proof' business, says B. Riley FBR
06/25/20 Benchmark
Benchmark sees material benefits if E.W. Scripps sells Stitcher
BRK.A Berkshire Hathaway
$350,950.00 /

-2050 (-0.58%)

07/07/20 Argus
Dominion price target lowered to $80 from $87 at Argus
07/06/20 Guggenheim
Guggenheim 'loves' Dominion gas transmission sale, decision to scrap pipeline
04/06/20 Citi
Delta not 'broken story' but share weakness may persist, says Citi
BRK.B Berkshire Hathaway
$233.53 /

-1.61 (-0.68%)

SSP E.W. Scripps
$14.85 /

-0.105 (-0.70%)

BRK.A Berkshire Hathaway
$350,950.00 /

-2050 (-0.58%)

SSP E.W. Scripps
$14.85 /

-0.105 (-0.70%)

BRK.B Berkshire Hathaway
$233.53 /

-1.61 (-0.68%)

BRK.A Berkshire Hathaway
$350,950.00 /

-2050 (-0.58%)

SSP E.W. Scripps
$14.85 /

-0.105 (-0.70%)

BRK.A Berkshire Hathaway
$350,950.00 /

-2050 (-0.58%)

Hot Stocks
Berkshire Hathaway reports 24.9% passive stake in E.W. Scripps » 17:24
01/15/21
01/15
17:24
01/15/21
17:24
SSP

E.W. Scripps

$14.85 /

-0.105 (-0.70%)

Berkshire Hathaway…

Berkshire Hathaway disclosed a 24.9% stake in E.W. Scripps , which represents over 23M shares. The filing does not allow for activism.

ShowHide Related Items >><<
SSP E.W. Scripps
$14.85 /

-0.105 (-0.70%)

SSP E.W. Scripps
$14.85 /

-0.105 (-0.70%)

10/22/20
Fly Intel: Top five analyst initiations
10/22/20 Guggenheim
E.W. Scripps resumed with a Buy at Guggenheim
07/07/20
Stitcher would help Sirius 'future-proof' business, says B. Riley FBR
06/25/20 Benchmark
Benchmark sees material benefits if E.W. Scripps sells Stitcher
SSP E.W. Scripps
$14.85 /

-0.105 (-0.70%)

SSP E.W. Scripps
$14.85 /

-0.105 (-0.70%)

SSP E.W. Scripps
$14.85 /

-0.105 (-0.70%)

Periodicals
Alimentation Couche-Tard, Carrefour abandon merger talks, Reuters says » 17:23
01/15/21
01/15
17:23
01/15/21
17:23
ANCUF

Alimentation Couche-Tard

$0.00 /

+ (+0.00%)

, CRRFY

Carrefour

$0.00 /

+ (+0.00%)

Alimentation Couche-Tard…

Alimentation Couche-Tard (ANCUF) has abandoned its efforts to acquire Carrefour (CRRFY) after its acquisition proposal ran into stiff opposition from the French government, Reuters' Pamela Barbaglia reports, citing a source familiar with the matter. The decision to end merger negotiations came after a meeting between French Finance Minister Bruno Le Maire and Couche-Tard's founder and chairman, Alain Bouchard, the author says. Reference Link

ShowHide Related Items >><<
ANCUF Alimentation Couche-Tard
$0.00 /

+ (+0.00%)

ANCUF Alimentation Couche-Tard
$0.00 /

+ (+0.00%)

01/15/21 CIBC
Alimentation Couche-Tard price target lowered to C$46 from C$52 at CIBC
01/15/21 Barclays
Alimentation Couche-Tard downgraded to Equal Weight from Overweight at Barclays
01/08/21 TD Securities
Alimentation Couche-Tard downgraded to Hold from Buy at TD Securities
12/01/20 Goldman Sachs
Alimentation Couche-Tard initiated with a Neutral at Goldman Sachs
CRRFY Carrefour
$0.00 /

+ (+0.00%)

10/12/20 JPMorgan
Carrefour should be building momentum in France, says JPMorgan
07/31/20 Berenberg
Carrefour price target raised to EUR 15.10 from EUR 14.80 at Berenberg
06/22/20 JPMorgan
Carrefour upgraded to Overweight from Neutral at JPMorgan
ANCUF Alimentation Couche-Tard
$0.00 /

+ (+0.00%)

Syndicate
ProPhase Labs files to sell common stock, no amount given » 17:22
01/15/21
01/15
17:22
01/15/21
17:22
PRPH

ProPhase Labs

$15.80 /

+0.35 (+2.27%)

ThinkEquity, a division…

ThinkEquity, a division of Fordham Financial Management, Inc., is acting as sole book-running manager for the Offering.

ShowHide Related Items >><<
PRPH ProPhase Labs
$15.80 /

+0.35 (+2.27%)

PRPH ProPhase Labs
$15.80 /

+0.35 (+2.27%)

Hot Stocks
NTN Buzztime receives noncompliance notice from NYSE American » 17:19
01/15/21
01/15
17:19
01/15/21
17:19
NTN

NTN Buzztime

$2.42 /

-0.185 (-7.10%)

NTN Buzztime announced it…

NTN Buzztime announced it received a letter from the NYSE Regulation stating that it is not in compliance with NYSE American LLC continued listing standards. Specifically, the company is not in compliance with Section 704 of the NYSE American Company Guide because it did not hold an annual meeting during the fiscal year ended December 31, 2020.

ShowHide Related Items >><<
NTN NTN Buzztime
$2.42 /

-0.185 (-7.10%)

Periodicals
Alimentation Couche-Tard, Carrefour to end merger talks, Bloomberg reports  17:18
01/15/21
01/15
17:18
01/15/21
17:18
CRRFY

Carrefour

$0.00 /

+ (+0.00%)

, ANCUF

Alimentation Couche-Tard

$0.00 /

+ (+0.00%)

 
ShowHide Related Items >><<
CRRFY Carrefour
$0.00 /

+ (+0.00%)

CRRFY Carrefour
$0.00 /

+ (+0.00%)

01/15/21 Barclays
Alimentation Couche-Tard downgraded to Equal Weight from Overweight at Barclays
10/12/20 JPMorgan
Carrefour should be building momentum in France, says JPMorgan
07/31/20 Berenberg
Carrefour price target raised to EUR 15.10 from EUR 14.80 at Berenberg
06/22/20 JPMorgan
Carrefour upgraded to Overweight from Neutral at JPMorgan
ANCUF Alimentation Couche-Tard
$0.00 /

+ (+0.00%)

01/15/21 CIBC
Alimentation Couche-Tard price target lowered to C$46 from C$52 at CIBC
01/08/21 TD Securities
Alimentation Couche-Tard downgraded to Hold from Buy at TD Securities
12/01/20 Goldman Sachs
Alimentation Couche-Tard initiated with a Neutral at Goldman Sachs
CRRFY Carrefour
$0.00 /

+ (+0.00%)

Syndicate
Kindred Biosciences files $150M mixed securities shelf  17:15
01/15/21
01/15
17:15
01/15/21
17:15
KIN

Kindred Biosciences

$4.93 /

-0.06 (-1.20%)

 
ShowHide Related Items >><<
KIN Kindred Biosciences
$4.93 /

-0.06 (-1.20%)

KIN Kindred Biosciences
$4.93 /

-0.06 (-1.20%)

12/24/20 Barclays
Kindred atopic dermatitis portfolio could net $130M in sales, says Barclays
12/18/20 Alliance Global Partners
Kindred Biosciences price target lowered to $9.25 from $10.25 at Alliance Global Partners
12/14/20 Lake Street
Kindred Biosciences struck 'terrific arrangement' with Elanco, says Lake Street
12/01/20 Alliance Global Partners
Kindred price target lowered to $10.25 from $12.50 at Alliance Global
KIN Kindred Biosciences
$4.93 /

-0.06 (-1.20%)

Hot Stocks
iRobot CEO sells 11.4K shares of common stock » 17:12
01/15/21
01/15
17:12
01/15/21
17:12
IRBT

iRobot

$89.32 /

+1.04 (+1.18%)

In a regulatory filing,…

In a regulatory filing, iRobot disclosed that its CEO Colin Angle sold 11.4K shares of common stock on January 13th in a total transaction size of $1.0M, reducing his stake by about 3%.

ShowHide Related Items >><<
IRBT iRobot
$89.32 /

+1.04 (+1.18%)

IRBT iRobot
$89.32 /

+1.04 (+1.18%)

10/22/20 Raymond James
iRobot upgraded on earnings upside potential at Raymond James
10/22/20 Raymond James
iRobot upgraded to Outperform from Market Perform at Raymond James
10/09/20 Northland
iRobot price target raised to $95 from $90 at Northland
07/23/20 Colliers
iRobot downgraded to Neutral from Buy at Colliers
IRBT iRobot
$89.32 /

+1.04 (+1.18%)

IRBT iRobot
$89.32 /

+1.04 (+1.18%)

IRBT iRobot
$89.32 /

+1.04 (+1.18%)

IRBT iRobot
$89.32 /

+1.04 (+1.18%)

Hot Stocks
Cloudera CEO sells 141.8K shares of common stock » 17:11
01/15/21
01/15
17:11
01/15/21
17:11
CLDR

Cloudera

$14.22 /

-0.23 (-1.59%)

In a regulatory filing,…

In a regulatory filing, Cloudera disclosed that its CEO Robert Bearden sold 141.8K shares of common stock on January 14th in a total transaction size of $2.03M, reducing his stake by about 18%.

ShowHide Related Items >><<
CLDR Cloudera
$14.22 /

-0.23 (-1.59%)

CLDR Cloudera
$14.22 /

-0.23 (-1.59%)

12/04/20 Citi
Cloudera price target raised to $14 from $12 at Citi
12/04/20 Barclays
Cloudera price target raised to $14 from $12 at Barclays
09/03/20 Northland
Cloudera price target raised to $13 from $11 at Northland
09/03/20 Barclays
Cloudera price target raised to $13 from $10 at Barclays
CLDR Cloudera
$14.22 /

-0.23 (-1.59%)

CLDR Cloudera
$14.22 /

-0.23 (-1.59%)

CLDR Cloudera
$14.22 /

-0.23 (-1.59%)

CLDR Cloudera
$14.22 /

-0.23 (-1.59%)

Hot Stocks
Huntington Ingalls awarded $174.91M Navy contract » 17:10
01/15/21
01/15
17:10
01/15/21
17:10
HII

Huntington Ingalls

$171.53 /

-0.275 (-0.16%)

Huntington Ingalls was…

Huntington Ingalls was awarded a $174.91M cost-plus-fixed-fee, indefinite-delivery/indefinite-quantity contract to provide Navy aircraft carrier Elevator Support Unit maintenance and repair. Work will be performed aboard Navy CVNs within the continental U.S.; outside the continental U.S.; and forward deployed locations according to individual task orders, and is expected to be completed by January 2026. No funds will be obligated at the time of award. Funding will be obligated on individual orders as they are issued. This contract was competitively procured and solicited via the beta.SAM.gov website. The Naval Sea Systems Command is the contracting activity.

ShowHide Related Items >><<
HII Huntington Ingalls
$171.53 /

-0.275 (-0.16%)

HII Huntington Ingalls
$171.53 /

-0.275 (-0.16%)

01/06/21 Vertical Research
Huntington Ingalls downgraded to Hold from Buy at Vertical Research
12/04/20 Alembic Global
Huntington Ingalls upgraded to Overweight from Neutral at Alembic Global
10/02/20 JPMorgan
Huntington Ingalls price target lowered to $175 from $205 at JPMorgan
10/01/20 Barclays
Huntington Ingalls price target lowered to $160 from $190 at Barclays
HII Huntington Ingalls
$171.53 /

-0.275 (-0.16%)

Hot Stocks
Lockheed Martin awarded $254.71M Missile Defense Agency contract » 17:08
01/15/21
01/15
17:08
01/15/21
17:08
LMT

Lockheed Martin

$347.34 /

-0.1 (-0.03%)

Lockheed Martin was…

Lockheed Martin was awarded a sole-source, cost-plus-incentive-fee, cost-plus-fixed-fee, firm-fixed-price definite contract under a Foreign Military Sales, or FMS, case to the United Arab Emirates, or UAE. The total value of this contract is $254.71M. Under this follow-on contract, the contractor will provide maintenance and sustainment for two Terminal High Altitude Area Defense batteries for UAE. The maintenance and sustainment scope of work includes providing logistics management, logistics product database, training, missile and ground repair and return, hardware/software development and sustainment, hardware in the loop, engineering services, missile field surveillance program and country unique specialty engineering for FMS client. The performance period is from January 15 through January 14, 2026. One offer was solicited and one offer was received. UAE FMS funds in the amount of $254,708,912 will be used to fund this effort. The Missile Defense Agency is the contracting activity.

ShowHide Related Items >><<
LMT Lockheed Martin
$347.34 /

-0.1 (-0.03%)

LMT Lockheed Martin
$347.34 /

-0.1 (-0.03%)

01/07/21 Baird
Lockheed Martin downgraded to Neutral from Outperform at Baird
01/07/21 Jefferies
Jefferies downgrades Aerojet Rocketdyne to Hold, sees higher bid as unlikely
12/22/20 Credit Suisse
Lockheed Martin price target raised to $409 from $400 at Credit Suisse
12/22/20 Truist
Aerojet Rocketdyne downgraded to Hold from Buy at Truist
LMT Lockheed Martin
$347.34 /

-0.1 (-0.03%)

LMT Lockheed Martin
$347.34 /

-0.1 (-0.03%)

LMT Lockheed Martin
$347.34 /

-0.1 (-0.03%)

Hot Stocks
Dycom COO sells 52K shares of common stock » 17:08
01/15/21
01/15
17:08
01/15/21
17:08
DY

Dycom

$87.71 /

-0.155 (-0.18%)

In a regulatory filing,…

In a regulatory filing, Dycom disclosed that its COO Timothy Estes sold 52K shares of common stock on January 13th in a total transaction size of $4.47M, reducing his stake by about 33%.

ShowHide Related Items >><<
DY Dycom
$87.71 /

-0.155 (-0.18%)

DY Dycom
$87.71 /

-0.155 (-0.18%)

01/07/21 B. Riley Securities
Dycom price target raised to $97 from $92 at B. Riley Securities
11/25/20 DA Davidson
Dycom price target raised to $80 from $60 at DA Davidson
11/24/20 Stifel
Dycom's 'weak' Q4 guidance and 'sizable' write down 'concerning,' says Stifel
11/23/20 Stifel
Dycom price target raised to $90 from $69 at Stifel
DY Dycom
$87.71 /

-0.155 (-0.18%)

Syndicate
Almaden Minerals files $60M mixed securities shelf  17:05
01/15/21
01/15
17:05
01/15/21
17:05
AAU

Almaden Minerals

$0.56 /

-0.0591 (-9.49%)

 
ShowHide Related Items >><<
AAU Almaden Minerals
$0.56 /

-0.0591 (-9.49%)

AAU Almaden Minerals
$0.56 /

-0.0591 (-9.49%)

12/22/20 Alliance Global Partners
Almaden Minerals price target lowered to $1.10 from $2 at Alliance Global Partners
12/03/20 Alliance Global Partners
Alliance Global sees buying opportunity at Almaden Minerals after Ixtaca ruling
09/22/20 Alliance Global Partners
Almaden Minerals initiated with a Buy at Alliance Global Partners
Syndicate
Salarius Pharmaceuticals files to sell 3.96M shares of common stock for holders  17:04
01/15/21
01/15
17:04
01/15/21
17:04
SLRX

Salarius Pharmaceuticals

$1.21 /

+0.05 (+4.31%)

 
ShowHide Related Items >><<
SLRX Salarius Pharmaceuticals
$1.21 /

+0.05 (+4.31%)

SLRX Salarius Pharmaceuticals
$1.21 /

+0.05 (+4.31%)

06/16/20 Benchmark
Salarius Pharmaceuticals initiated with a Speculative Buy at Benchmark
04/27/20
Fly Intel: Top five analyst initiations
04/27/20 Ladenburg
Salarius Pharmaceuticals initiated with a Buy at Ladenburg
  • 30
    Jul
SLRX Salarius Pharmaceuticals
$1.21 /

+0.05 (+4.31%)

Syndicate
EyePoint files $250M mixed securities shelf  17:04
01/15/21
01/15
17:04
01/15/21
17:04
EYPT

EyePoint

$10.94 /

-0.02 (-0.18%)

 
ShowHide Related Items >><<
EYPT EyePoint
$10.94 /

-0.02 (-0.18%)

EYPT EyePoint
$10.94 /

-0.02 (-0.18%)

01/12/21 B. Riley Securities
EyePoint price target raised to $8.50 from $5 at B. Riley Securities
01/07/21 Alliance Global Partners
Iluvien deal shows valuation disconnect at Alimera, says Alliance Global Partners
10/09/20
Fly Intel: Top five analyst upgrades
10/09/20 H.C. Wainwright
EyePoint upgraded to Buy from Neutral at H.C. Wainwright
EYPT EyePoint
$10.94 /

-0.02 (-0.18%)

  • 21
    Feb
Syndicate
Verb Technology files $75M mixed securities shelf  17:03
01/15/21
01/15
17:03
01/15/21
17:03
VERB

Verb Technology

$1.79 /

-0.09 (-4.79%)

 
ShowHide Related Items >><<
VERB Verb Technology
$1.79 /

-0.09 (-4.79%)

VERB Verb Technology
$1.79 /

-0.09 (-4.79%)

01/13/21 Alliance Global Partners
Verb Technology price target raised to $2.75 from $2 at Alliance Global Partners
12/14/20
Fly Intel: Top five analyst initiations
12/14/20 Ladenburg
Verb Technology initiated with a Buy at Ladenburg
07/13/20 Alliance Global Partners
Alliance Global Partners keeps a Buy rating on VERB after preliminary results
VERB Verb Technology
$1.79 /

-0.09 (-4.79%)

  • 22
    Jul
  • 07
    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.